European Heart Journal – Cardio-Oncology
Competing mortality and the interpretation of similar non-fatal MACE risk with second-generation BTK inhibitors
By Hasan Burak İşleyen and Zehra Sucuoglu.
Abstract
Hasan Burak Isleyen, MD, Zehra Sucuoglu, MD; Competing mortality and the interpretation of similar non-fatal MACE risk with second-generation BTK inhibitor
Keywords
- Chronic Lymphocytic Leukemia Research
- Open access
Source
Published in European Heart Journal – Cardio-Oncology. The abstract is shown as published and remains the work of its authors; read the full article at the source.
Prognia lists this article for reference and education. It is not medical advice. Always read the original and follow current guidelines and local protocols before acting on it.
At a glance
- Published
- 19 October 2026
- Specialty
- Oncology